英科医疗 (300677)

INTCO MEDICAL TECHNOLOGY CO., LTD.

ASZ

Tags

Medical DevicesPharmaceuticals and HealthcareFace Mask ProtectionGuozheng Value IndexGuozheng Growth IndexFund Increase PositionsSmall Cap ValueSmall Cap GrowthInstitutional AccumulationOverseas BusinessHigh-Performing StocksTencent Ji'an IndexCross-Border E-commerceChiNext 200 IndexChiNext 50 IndexChiNext IndexChiNext HealthcarePharma & BiotechSZSE Medicine Equal Weight IndexSina 100 IndexShenzhen A-Share Pharmaceutical IndexChiNext Equal Weight IndexCS High Dividend Yield IndexCSI All-share Pharmaceutical Sector IndexSZSE 700 IndexSSE 700 Growth IndexZhongchuang Growth IndexSZSE 1000 IndexCSSW Health IndexCSI 1000 Growth IndexSZSE Component Index ReturnCNI 1000 IndexCSI Medical IndexZhongchuang Value IndexOrient Securities Value IndexNew Virus PreventionJuly 2022 Lock-up ExpiryConvertible Bond IssuersInsurance Heavy HoldingsStocks Below Book ValuePublic Health IndexSmall-cap High Beta IndexCS High-end Manufacturing IndexSZSE Pharmaceutical IndexCSI 800 IndexCS Pharmaceutical TI IndexCNI Pharmaceutical IndexCSI 1000 Pharmaceutical IndexJuchao Small-cap IndexChiNext Basic IndexChina United Quality Growth IndexSZSE Component Pharmaceutical IndexCSI All-share Pharmaceutical IndexSZSE Pharmaceutical 50 IndexChiNext Low Volatility IndexCSI 500 Equal Weight IndexSZSE Component Index Equal WeightCSI 700 IndexAH Economic Blue-chip IndexMid-small Cap IndexSZSE Fundamental 200 IndexCSI 500 IndexCSI 500 IndexZhongchuang High Beta IndexZhongchuang Low Volatility IndexChiNext Manufacturing IndexZhongchuang 400 IndexChiNext Growth IndexESG 300 IndexCR New Momentum IndexChiNext Return IndexCSI 1000 Value IndexSZSE 500 IndexFundamental 600 IndexCSI 500 ESG IndexChiNext Growth IndexShandong

K-Line Chart

No K-line data available

Company NameIntco Medical Technology Co., Ltd.
Listing Date2017-07-21
Issue Price20.39RMB
Registered Capital65438.326310k RMB
Legal RepresentativeLiu Fangyi
Registered AddressNo. 18 Qingtian Road, Qilu Chemical Industrial Park, Linzi District, Zibo City, Shandong Province
IndustryMedical Devices
Main BusinessThe issuer is a comprehensive medical care product supplier. Its main business covers four major segments: medical protection, rehabilitation care, health physiotherapy, and examination consumables.
Company ProfileShandong Intco Medical Products Co., Ltd. was founded in 2009 in Zibo City, Shandong Province. Its main business covers four major segments: medical protection, rehabilitation care, health physiotherapy, and examination consumables. Its main products include various types of care products such as disposable gloves, wheelchairs, hot/cold packs, and electrode pads. The products are widely used in medical institutions, elderly care facilities, household daily use, and other related industries. After years of development, Intco Medical now has ten subsidiaries globally, with sales offices in Shanghai, Los Angeles (USA), Canada, Malaysia, and Germany.

Stock Details

1. Key Indicators

  • Total Shares(W): 65516.37
  • Circulating A-Shares(W): 46559.68
  • Earnings Per Share(RMB): 1.4500
  • Net Assets Per Share(RMB): 27.7338
  • Operating Revenue(W RMB): 742471.48
  • Total Profit(W RMB): 106049.15
  • Net Profit Attributable to Parent(W RMB): 92441.07
  • Net Profit Growth Rate(%): 34.47
  • Weighted Return on Equity(%): 5.1900
  • Operating Cash Flow Per Share(RMB): 1.6900
  • Undistributed Profit Per Share(RMB): 24.9795
  • Capital Reserve Per Share(RMB): 1.7894

2. Main Business

The main business covers:

  • Personal Protection
  • Rehabilitation and Nursing Care
  • Other Products

3. Company Basic Information

  • Company Name: Intco Medical Technology Co., Ltd.
  • Listing Date: 2017-07-21
  • Industry: Medical Devices
  • Address: No. 18 Qingtian Road, Qilu Chemical Industrial Park, Linzi District, Zibo City, Shandong Province
  • Website: www.intcomedical.com.cn
  • Company Profile：The Company was established as a joint stock limited company by the overall change of Zibo Intco Medical Products Co., Ltd. On April 17, 2015, the limited company was converted into a joint stock company with the audited net assets as of December 31, 2014 converted into a share capital of 60 million yuan. On June 11, 2015, the joint stock company increased its capital to 63.16 million yuan. On June 25, 2015, the joint stock company increased its capital to 68,774,173 yuan. On December 28, 2015, the company increased its capital to 72,929,480 yuan.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 HuaBao CSI Medical ETF Fund 1280.02 2.75
2 E Fund ChiNext ETF Fund 901.11 1.94
3 Hong Kong Securities Clearing Company Ltd. Northbound Capital 779.74 1.68
4 CSI 500 ETF Fund 659.50 1.42
5 JY New Vitality Flexible Allocation Hybrid Securities Investment Fund A Fund 432.68 0.93
6 Nord Value Advantage Hybrid Securities Investment Fund Fund 427.36 0.92
7 JY Trend Priority Hybrid Securities Investment Fund A Fund 425.93 0.92
8 GT Juxin Value Advantage Flexible Allocation Hybrid Securities Investment Fund A Fund 416.00 0.89
9 JY Qicheng Hybrid Securities Investment Fund A Fund 303.79 0.65
10 GF Jurui Hybrid Securities Investment Fund A Fund 283.17 0.61

5. Concept Sectors

  • Wind Power
  • Elderly Care Concept
  • Cross-border E-commerce
  • Mask Protection
  • Green Power
  • Margin Trading & Securities Lending
  • High-performing Stock
  • Overseas Business
  • Funds Increasing Holdings
  • Institutions Accumulating Shares
  • ChiNext Index
  • Tencent Ji'an
  • ChiNext 300
  • ChiNext Medical

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information